The recurrence of prostate cancer can now be detected 14.8 months sooner than existing clinical practices with new technology developed by a professor at Purdue University in West Lafayette, Ind.
The Latest
After nine years, Baltimore-based Johns Hopkins and Pittsburgh-based Allegheny Health Network have announced that they will end their cancer center collaboration, TribLive reported Oct. 6.
Duarte, Calif.-based City of Hope will open the first multicenter clinical trial in the U.S. to test robotically assisted mastectomies, according to an Oct. 3 news release shared with Becker's.
Hung-Chi Ho, MD, a board-certified radiation oncologist at University of Pittsburgh Medical Center's Hillman Cancer Center in Butler, Pa., will retire after a 37-year career with the health system.
Rochester, Minn.-based Mayo Clinic is utilizing artificial intelligence to achieve earlier detection of pancreatic cancer in patients while the disease is still curable, according to an Oct. 2 news release.
Patients who have multiple myeloma and also diabetes are at an increased risk of lower survival rates, but new research shows this differs by race.
Healthcare professionals said health disparities and inadequate treatment options are their top concerns in oncology, according to a recent poll from Becker's on LinkedIn.
Six types of cancer were underdiagnosed during the pandemic, according to the National Institutes of Health.
Boston-based Mass General Cancer Center has received the largest philanthropic gift in its history to be put toward future cancer research, according to a Sept. 27 news release.
Joseph Rosales, MD, was considering a few different specialties during training, but what drew him to oncology was the ability to have "very close and intense relationships with patients."